+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Ventilation and Anesthesia Masks Market Size, Share and Trends Analysis Report by Mask Type (Disposable, Reusable), Application (Operating Rooms, ICU, Emergency Rooms, Homecare), and Region 2024-2030

  • PDF Icon

    Report

  • 100 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 6009821
The global artificial ventilation and anesthesia masks market size is anticipated to reach USD 3.30 billion by 2030. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.

Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.

According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.

The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.

The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.

Artificial Ventilation And Anesthesia Masks Market Report Highlights

  • Disposable masks accounted for the largest revenue share of 68.0% in 2023. The dominance of disposable masks in the medical industry is driven by their cost-effectiveness, user convenience, reduced infection risk, and adherence to legal requirements.
  • The operating rooms application segment dominated the market with a revenue share of 32.0% in 2023. Operating rooms have modern working ventilation systems and devices for anesthesia where one is able to control in detail the amount of air circulation and the concentration of the anesthetic mixture.
  • Reusable masks are expected to grow significantly over the forecast period, registering a CAGR of 4.6%. Reusable masks offer a cost-effective solution for hospitals, as they can be cleaned and reused, reducing waste and minimizing costs.
  • North America artificial ventilation and anesthesia masks market dominated the global artificial ventilation and anesthesia masks market with a revenue share of 36.1% in 2023.

The leading players in the Artificial Ventilation and Anesthesia Masks market include:

  • GaleMed Corporation.
  • Drägerwerk AG & Co. KGaA
  • BD
  • Air Liquide Medical Systems
  • Koninklijke Philips N.V.
  • ResMed
  • Ambu A/S
  • VYAIRE MEDICAL, INC.
  • NIHON KOHDEN CORPORATION
  • Hamilton Medical
  • Thermo Fisher Scientific Inc.
  • Medtronic

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Artificial Ventilation and Anesthesia Masks Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Artificial Ventilation and Anesthesia Masks Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Artificial Ventilation and Anesthesia Masks Market: Masks Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Artificial Ventilation and Anesthesia Masks Market: Masks Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Disposable Masks
4.3.1. Disposable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Reusable Masks
4.4.1. Reusable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Operating Rooms
5.3.1. Operating Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. ICU
5.4.1. ICU Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.5. Emergency Rooms
5.5.1. Emergency Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Homecare
5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. ASCs
5.7.1. ASCs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Artificial Ventilation and Anesthesia Masks Market: Regional Estimates & Trend Analysis
6.1. Artificial Ventilation and Anesthesia Masks Market Share, By Region, 2023 & 2030 (USD Billion)
6.2. North America
6.2.1. North America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.2. U.S.
6.2.2.1. U.S. Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.3. Canada
6.2.3.1. Canada Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.2.4. Mexico
6.2.4.1. Mexico Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3. Europe
6.3.1. Europe Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.2. UK
6.3.2.1. UK Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.3. Germany
6.3.3.1. Germany Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.4. France
6.3.4.1. France Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.5. Italy
6.3.5.1. Italy Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.6. Spain
6.3.6.1. Spain Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.7. Denmark
6.3.7.1. Denmark Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.8. Sweden
6.3.8.1. Sweden Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.3.9. Norway
6.3.9.1. Norway Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Asia Pacific
6.4.1. Asia Pacific Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.2. China
6.4.2.1. China Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.3. Japan
6.4.3.1. Japan Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.4. India
6.4.4.1. India Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.5. Australia
6.4.5.1. Australia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.6. South Korea
6.4.6.1. South Korea Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.7. Thailand
6.4.7.1. Thailand Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Latin America
6.5.1. Latin America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.2. Brazil
6.5.2.1. Brazil Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.3. Argentina
6.5.3.1. Argentina Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.2. South Africa
6.6.2.1. South Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.4. UAE
6.6.4.1. UAE Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.5. Kuwait
6.6.5.1. Kuwait Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. GaleMed Corporation.
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/Strategic Initiatives
7.4.2. Drägerwerk AG & Co. KGaA
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/Strategic Initiatives
7.4.3. BD
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/Strategic Initiatives
7.4.4. Air Liquide Medical Systems
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/Strategic Initiatives
7.4.5. Koninklijke Philips N.V.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/Strategic Initiatives
7.4.6. ResMed
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/Strategic Initiatives
7.4.7. Ambu A/S
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/Strategic Initiatives
7.4.8. VYAIRE MEDICAL, INC.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/Strategic Initiatives
7.4.9. NIHON KOHDEN CORPORATION
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/Strategic Initiatives
7.4.10. Hamilton Medical
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/Strategic Initiatives
7.4.11. Thermo Fisher Scientific Inc.
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/Strategic Initiatives
7.4.12. Medtronic
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/Strategic Initiatives

Companies Mentioned

The leading players in the Artificial Ventilation and Anesthesia Masks market include:
  • GaleMed Corporation.
  • Drägerwerk AG & Co. KGaA
  • BD
  • Air Liquide Medical Systems
  • Koninklijke Philips N.V.
  • ResMed
  • Ambu A/S
  • VYAIRE MEDICAL, INC.
  • NIHON KOHDEN CORPORATION
  • Hamilton Medical
  • Thermo Fisher Scientific Inc.
  • Medtronic

Methodology

Loading
LOADING...

Table Information